(Q58212638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

Adrian Harris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

M F Bassendine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

H Loose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

O F James

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 June 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

349-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

The natural history of hepatocellular carcinoma. A study of 100 untreated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Induction of remission in hepatocellular carcinoma with doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Hepatic artery infusion chemotherapy in hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Growth Characteristics of α-Foetoprotein-Secreting Human Hepatocellular Carcinoma in Athymic (Nude) Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Serum Alpha-Fetoprotein Estimations and Doubling Time in Hepatocellular Carcinoma: Influence of Therapy and Possible Value in Early Detection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980545-7

7 January 2021

10.1016/S0168-8278(87)80545-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2439582%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference